In response: Considerations regarding compounding pharmacies and GLP-1 agonists

被引：0
|
作者：
Long, Brit [1 ,2 ]
Pelletier, Jessica [3 ]
Koyfman, Alex [4 ]
Bridwell, Rachel E. [5 ]
机构：
[1] Brooke Army Med Ctr, Dept Emergency, Ft Sam Houston, TX USA
[2] 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA
[3] Washington Univ, Sch Med, Dept Emergency Med, St Louis, MO USA
[4] UT Southwestern, Dept Emergency Med, Dallas, TX USA
[5] Madigan Army Med Ctr, Dept Emergency Med, Tacoma, WA USA
来源：
AMERICAN JOURNAL OF EMERGENCY MEDICINE | 2024年 / 80卷
关键词：
D O I：
10.1016/j.ajem.2024.03.037
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [1] GLP-1 Receptor Agonists: Practical Considerations for Clinical Practice
    Triplitt, Curtis
    Solis-Herrera, Carolina
    [J]. DIABETES EDUCATOR, 2015, 41 : 32S - 46S
  • [2] GLP-1 Agonists for Obesity
    Langland, James T.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [3] GLP-1 Agonists for Obesity
    Kurian, Marina
    Rogers, Ann M.
    Peterson, Richard M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [4] GLP-1 Agonists for Obesity
    Dellgren, Johan
    Emanuel, Ezekiel J.
    Persad, Govind
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [5] GLP-1 Agonists for Obesity
    Mozaffarian, Dariush
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [6] GLP-1 Agonists for Obesity
    Moran, Alyssa J.
    Roberto, Christina A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [7] GLP-1 agonists for type 2 diabetes: pharnnacokinetic and toxicological considerations
    Jespersen, Maria J.
    Knop, Filip K.
    Christensen, Mikkel
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (01) : 17 - 29
  • [8] GLP-1 receptor variants markedly differentiate glycaemic response to GLP-1 receptor agonists: a DIRECT study
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. G.
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I.
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    [J]. DIABETOLOGIA, 2017, 60 : S393 - S393
  • [9] GLP-1 RECEPTOR VARIANTS MARKEDLY DIFFERENTIATE GLYCAEMIC RESPONSE TO GLP-1 RECEPTOR AGONISTS: A DIRECT STUDY
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. -G
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 13 - 14
  • [10] GLP-1 receptor agonists in NAFLD
    Petit, J. -M.
    Verges, B.
    [J]. DIABETES & METABOLISM, 2017, 43 : 2S28 - 2S33
12345